Latest Sierra Sciences Stories
Researchers at UT Southwestern Medical Center have found that alternative splicing – a process that allows a single gene to code for multiple proteins – appears to be a new potential target for anti-telomerase cancer therapy.
The cure for cancer comes down to this: video games.
Researchers have revealed how a molecule called telomerase contributes to the control of the integrity of our genetic code, and when it is involved in the deregulation of the code, its important role in the development of cancer.
NEW YORK, June 8, 2011 /PRNewswire/ -- When expressed (turned on), the gene (hTERT) located on Chromosome number 5p15.33 activates the enzyme telomerase. Human cells can keep living and dividing indefinitely when telomerase is continually present; i.e. the cells become immortal.
Cancer researchers at UT Southwestern Medical Center are helping unlock the cellular-level function of the telomerase enzyme, which is linked to the disease's growth.
LOS ANGELES, March 17, 2011 /PRNewswire/ -- Genesis Biopharma, Inc. (OTC Bulletin Board: GNBP), a biotechnology company developing targeted cancer therapies, today announced it has appointed William H. Andrews Ph.D. to its Board of Directors. Dr.
Age management leader Cenegenics® Medical Institute announced an added dimension to its highly regarded proactive approach for optimized health, the patented TA-65® Las Vegas, NV (Vocus/PRWEB) March 15, 2011 Cenegenics® Medical Institute, the global age management medicine leader, announced a new addition to its renowned proactive approach to prevent or delay age-related disease for optimized health: telomere science.
NEW YORK, Jan. 13, 2011 /PRNewswire/ -- Telomerase Activation Sciences, Inc. (T.A. Sciences) today announced the issuance of U.S. Patent No. 7,846,904 to the Geron Corporation. The patent covers the use of certain compounds to upregulate telomerase expression in cells. T.A.
RENO, Nev., Nov. 30, 2010 /PRNewswire/ -- On Sunday, a team of scientists at Harvard Medical School led by Dr. Ronald DePinho published research providing strong scientific support for the validity of Sierra Sciences' approach to curing aging.